BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12853699)

  • 1. Haemoglobin E/beta-thalassaemia - an experience in the eastern Indian state of Orissa.
    Chhotray GP; Dash BP; Ranjit MR; Cohla RB; Mohanty D
    Acta Haematol; 2003; 109(4):214-6. PubMed ID: 12853699
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemoglobin E disease in North Indian population: a report of 11 cases.
    Kishore B; Khare P; Gupta RJ; Bisht S; Majumdar K
    Hematology; 2007 Aug; 12(4):343-7. PubMed ID: 17654063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygosity of non-deletional hereditary persistence of fetal hemoglobin and deltabeta-thalassemia.
    Kalamaras A; Chassanidis C; Samara M; Papadakis MN; Vagena A; Aleporou-Marinou V; Patrinos GP; Kollia P
    Am J Hematol; 2008 Sep; 83(9):760. PubMed ID: 18615450
    [No Abstract]   [Full Text] [Related]  

  • 4. Wide range of F cell levels in healthy Thai adults: Influence of Swiss-type hereditary persistence of foetal haemoglobin & β-haemoglobinopathy.
    Tatu T
    Indian J Med Res; 2019 Aug; 150(2):161-166. PubMed ID: 31670271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of β-Thalassemia and hemoglobin E in two migrant populations of Manipur, North East India.
    Achoubi N; Asghar M; Saraswathy KN; Murry B
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1195-200. PubMed ID: 23057593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of hemoglobin E with other abnormal hemoglobins.
    Edison ES; Shaji RV; Chandy M; Srivastava A
    Acta Haematol; 2011; 126(4):246-8. PubMed ID: 21986214
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemoglobin E-beta-thalassaemia; a study of eight cases in Northwest India.
    Ghosh K; Chakrabarty AK; Mohanty D; Das KC
    Trop Geogr Med; 1983 Sep; 35(3):267-71. PubMed ID: 6196886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hemoglobinopathies in rural Bengal, India.
    Dolai TK; Dutta S; Bhattacharyya M; Ghosh MK
    Hemoglobin; 2012; 36(1):57-63. PubMed ID: 22004064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of hemoglobin E/β-thalassemia compound heterozygotes with low hemoglobin F phenotype among cases with a diagnosis of hemoglobin E homozygote, determined by high-performance liquid chromatography, in prenatal control program for β-thalassemia.
    Wong P; Srichaiya A; Suannum P; Charoenporn P; Jermnim S; Chan-In M; Tapprom A; Deoisares R
    Ann Hematol; 2017 Oct; 96(10):1763-1765. PubMed ID: 28803407
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterocellular hereditary persistence of fetal haemoglobin affects the haematological parameters of beta-thalassaemia trait.
    Garner C; Dew TK; Sherwood R; Rees D; Thein SL
    Br J Haematol; 2003 Oct; 123(2):353-8. PubMed ID: 14531920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HbA2 levels in normal, beta-thalassaemia and haemoglobin E carriers by capillary electrophoresis.
    Hafiza A; Malisa MY; Khirotdin RD; Azlin I; Azma Z; Thong MC; Ali IM; Yeoh ZN; Mohd Ishak L; Mohd Radzi NR; Hussin NH
    Malays J Pathol; 2012 Dec; 34(2):161-4. PubMed ID: 23424780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematological and molecular analysis of beta-thalassemia and Hb Lepore in Campania, Italy.
    Ferrara M; Matarese SM; Francese M; Borrelli B; Coppola L; Coppola A; Esposito L
    Hemoglobin; 2001 Feb; 25(1):29-34. PubMed ID: 11300347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
    Balgir RS
    J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-thalassemia in Brazil.
    Zago MA; Costa F; Bottura C
    Braz J Med Biol Res; 1981 Dec; 14(6):383-8. PubMed ID: 6086110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hb Siam [alpha15(A13)Gly-->Arg (alpha1) (GGT-->CGT)] is a typical alpha chain hemoglobinopathy without an alpha-thalassemic effect.
    Turbpaiboon C; Svasti S; Sawangareetakul P; Winichagoon P; Srisomsap C; Siritanaratkul N; Fucharoen S; Wilairat P; Svasti J
    Hemoglobin; 2002 Feb; 26(1):77-81. PubMed ID: 11939517
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatic deletion of the normal beta-globin gene leading to thalassaemia intermedia in heterozygous beta-thalassaemic patients.
    Galanello R; Perseu L; Perra C; Maccioni L; Barella S; Longinotti M; Cao A; Cazzola M
    Br J Haematol; 2004 Dec; 127(5):604-6. PubMed ID: 15566365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-deletion hereditary persistence of fetal hemoglobin (HPFH) determinant not linked to the beta-globin gene complex.
    Thein SL; Weatherall DJ
    Prog Clin Biol Res; 1989; 316B():97-111. PubMed ID: 2482508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular studies of haemoglobin-E in tribal populations of Tripura.
    De M; Chakraborty G; Das SK; Bhattacharya DK; Talukder G
    Lancet; 1997 May; 349(9061):1297. PubMed ID: 9142071
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular basis and hematologic characterization of deltabeta-thalassemia and hereditary persistence of fetal hemoglobin in Thailand.
    Panyasai S; Fucharoen S; Surapot S; Fucharoen G; Sanchaisuriya K
    Haematologica; 2004 Jul; 89(7):777-81. PubMed ID: 15257928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.